Health News Headlines – Yahoo News
Spectrum Pharma’s cancer drug meets main goal in trial
(Reuters) – Spectrum Pharmaceuticals Inc said its experimental blood cancer drug was shown to be safe and effective in a mid-stage trial, sending its shares up 10 percent. The injectable drug, Captisol-enabled melphalan, an improved form of common chemotherapy drug melphalan, is being tested in patients with multiple myeloma undergoing stem cell transplants. High-dose chemotherapy in combination with stem cell transplants is an option for patients with multiple myeloma, a form of blood cancer that originates in the bone marrow. The higher dose of chemotherapy given during the treatment destroys more myeloma cells.